Richard J Miron1,2,3,4, Qiao Zhang5, Anton Sculean6, Daniel Buser7, Benjamin E Pippenger8, Michel Dard9, Yoshinori Shirakata10, Fatiha Chandad11, Yufeng Zhang12. 1. The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan, 430079, People's Republic of China. richard.miron@zmk.unibe.ch. 2. Faculté de Medecine Dentaire, Pavillon de Médecine Dentaire, Université de Laval, 2420 rue de la Terrasse, Québec, G1V 0A6, Canada. richard.miron@zmk.unibe.ch. 3. Department of Periodontology, University of Bern, School of Dental Medicine, Bern, Switzerland. richard.miron@zmk.unibe.ch. 4. Department of Oral Surgery and Stomatology, School of Dental Medicine, University of Bern, Bern, Switzerland. richard.miron@zmk.unibe.ch. 5. The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan, 430079, People's Republic of China. 6. Department of Periodontology, University of Bern, School of Dental Medicine, Bern, Switzerland. 7. Department of Oral Surgery and Stomatology, School of Dental Medicine, University of Bern, Bern, Switzerland. 8. Institut Straumann AG, Basel, Switzerland. 9. Department of Periodontology and Implant Dentistry, New York University, New York, NY, USA. 10. Department of Periodontology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. 11. Faculté de Medecine Dentaire, Pavillon de Médecine Dentaire, Université de Laval, 2420 rue de la Terrasse, Québec, G1V 0A6, Canada. 12. The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, 237 Luoyu Road, Wuhan, 430079, People's Republic of China. zyf@whu.edu.cn.
Abstract
OBJECTIVES: Guided bone regeneration (GBR) aims to predictably restore missing bone that has been lost due to trauma, periodontal disease or a variety of systemic conditions. Critical to this procedure is the ability of a bone grafting material to predictably serve as a 3-dimensional scaffold capable of inducing cell and bone tissue in-growth at the material surface. Although all bone grafts are osteoconductive to bone-forming osteoblasts, only a small number of commercially available bone grafts with FDA approval are osteoinductive including demineralized freeze-dried bone allographs (DFDBA) and scaffolds containing bone morphogenetic proteins (BMPs). Recently, a class of synthetic bone grafts fabricated from biphasic calcium phosphate (BCP) sintered at a low temperature have been shown to form ectopic bone formation in non-skeletal sites without the use of growth factors. Therefore, the present study aimed to compare the osteoinductive potential of this group of synthetic BCP alloplasts with autografts, allografts and xenografts. MATERIALS AND METHODS: In the present study, 4 types of bone grafting materials including autogenous bone harvested with a bone mill, DFDBA (LifeNet, USA), a xenograft derived from bovine bone mineral (NBM, BioOss, Geistlich, Switzerland) and a novel synthetic biphasic calcium phosphate (BCP, Straumman, Switzerland) were implanted into intramuscular pouches of 24 rats and analysed histologically for their ability to form ectopic bone formation around grafting particles. A semi-quantitative osteoinductive score was used to quantify the osteoinductive ability of each bone graft. RESULTS: The results from the present study reveal that (1) autogenous bone resorbed rapidly in vivo, (2) the xenograft showed no potential to form ectopic bone formation and (3) both DFDBA and BCP were able to stimulate ectopic bone formation. CONCLUSION: These studies demonstrate that these newly developed synthetic bone grafts have potential for inducing ectopic bone formation similar to DFDBA. Future clinical testing is necessary to reveal their bone-inducing properties in clinical scenarios including GBR procedures and in combination with implant dentistry. CLINICAL RELEVANCE: Novel BCP scaffolds are able to induce ectopic bone formation without the use of osteoinductive growth factors such as BMP2 and thus demonstrate a large clinical possibility to further enhance bone formation for a variety of clinical procedures.
OBJECTIVES: Guided bone regeneration (GBR) aims to predictably restore missing bone that has been lost due to trauma, periodontal disease or a variety of systemic conditions. Critical to this procedure is the ability of a bone grafting material to predictably serve as a 3-dimensional scaffold capable of inducing cell and bone tissue in-growth at the material surface. Although all bone grafts are osteoconductive to bone-forming osteoblasts, only a small number of commercially available bone grafts with FDA approval are osteoinductive including demineralized freeze-dried bone allographs (DFDBA) and scaffolds containing bone morphogenetic proteins (BMPs). Recently, a class of synthetic bone grafts fabricated from biphasic calcium phosphate (BCP) sintered at a low temperature have been shown to form ectopic bone formation in non-skeletal sites without the use of growth factors. Therefore, the present study aimed to compare the osteoinductive potential of this group of synthetic BCP alloplasts with autografts, allografts and xenografts. MATERIALS AND METHODS: In the present study, 4 types of bone grafting materials including autogenous bone harvested with a bone mill, DFDBA (LifeNet, USA), a xenograft derived from bovine bone mineral (NBM, BioOss, Geistlich, Switzerland) and a novel synthetic biphasic calcium phosphate (BCP, Straumman, Switzerland) were implanted into intramuscular pouches of 24 rats and analysed histologically for their ability to form ectopic bone formation around grafting particles. A semi-quantitative osteoinductive score was used to quantify the osteoinductive ability of each bone graft. RESULTS: The results from the present study reveal that (1) autogenous bone resorbed rapidly in vivo, (2) the xenograft showed no potential to form ectopic bone formation and (3) both DFDBA and BCP were able to stimulate ectopic bone formation. CONCLUSION: These studies demonstrate that these newly developed synthetic bone grafts have potential for inducing ectopic bone formation similar to DFDBA. Future clinical testing is necessary to reveal their bone-inducing properties in clinical scenarios including GBR procedures and in combination with implant dentistry. CLINICAL RELEVANCE: Novel BCP scaffolds are able to induce ectopic bone formation without the use of osteoinductive growth factors such as BMP2 and thus demonstrate a large clinical possibility to further enhance bone formation for a variety of clinical procedures.
Entities:
Keywords:
Bone grafts; Natural bone mineral; Osteoinduction; Osteoinductive potential
Authors: Richard J Miron; Dieter D Bosshardt; Oliver Laugisch; Christos Katsaros; Daniel Buser; Anton Sculean Journal: J Periodontol Date: 2011-11-28 Impact factor: 6.993
Authors: Z Schwartz; T Weesner; S van Dijk; D L Cochran; J T Mellonig; C H Lohmann; D L Carnes; M Goldstein; D D Dean; B D Boyan Journal: J Periodontol Date: 2000-08 Impact factor: 6.993
Authors: Noel L Davison; Anne-Laure Gamblin; Pierre Layrolle; Huipin Yuan; Joost D de Bruijn; Florence Barrère-de Groot Journal: Biomaterials Date: 2014-03-31 Impact factor: 12.479
Authors: Lana Sarita de Souza de Oliveira; Aurigena Antunes de Araújo; Raimundo Fernandes de Araújo Júnior; Carlos Augusto Galvão Barboza; Boniek Castillo Dutra Borges; José Sandro Pereira da Silva Journal: Int J Exp Pathol Date: 2017-05-29 Impact factor: 1.925